[1]Kitajima K, Kaji Y, Sugimura K. Usual and unusual MRI findings of ovarian fibroma: correlation with pathologic findings [J]. Magn Reson Med Sci, 2008,7(1):43-48.[2]Outwater EK, Wagner BJ, Mannion C, et al. Sex cord-stromal and steroid cell tumors of the ovary [J]. Radiographics, 1998,18(6):1523-1546.[3]Chiou SY, Lev-Toaff AS, Masuda E, et al. Adnexal torsion: new clinical and imaging observations by sonography, computed tomography, and magnetic resonance imaging [J]. J Ultrasound Med, 2007,26(10):1289-1301.[4]Leung SW, Yuen PM. Ovarian fibroma: a review on the clinical characteristics, diagnostic difficulties, and management options of 23 cases [J]. Gynecol Obstet Invest, 2006,62(1):1-6.[5]Gargano G, De Lena M, Zito F, et al. Ovarian fibroma: our experience of 34 cases [J]. Eur J Gynaecol Oncol, 2003,24(5):429-432.[6]Chen YJ, Hsieh CS, Eng HL, et al. Ovarian fibroma in a 7-month-old infant: a case report and review of the literature [J]. Pediatr Surg Int, 2004,20(11-12):894-897.[7]俞琳玲, 潘芝梅, 楼芬兰. 卵巢纤维瘤CT诊断 (附16例分析) [J]. 实用放射学杂志, 2001,17(9):2.[8]Benjapibal M, Sangkarat S, Laiwejpithaya S, et al. Meigs' syndrome with elevated serum CA125: case report and review of the literature [J]. Case Rep Oncol, 2009,2(1):61-66.[9]Thomassin-Naggara I, Darai E, Nassar-Slaba J, et al. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma [J]. J Comput Assist Tomogr, 2007,31(2):236-242.[10]Shanbhogue AK, Shanbhogue DK, Prasad SR, et al. Clinical syndromes associated with ovarian neoplasms: a comprehensive review [J]. Radiographics, 2010,30(4):903-919.[11]Cecchi E, Lapi F, Vannacci A, et al. Increased levels of CA 125 and CA 19.9 serum tumour markers following cyclic combined hormone replacement therapy [J]. J Clin Pharm Ther, 2009,34(1):129-132. |